摘要
Abstract
Objective To explore the clinical effect of human immunoglobulin in the adjuvant treatment of severe pneumonia in children.Methods A total of 76 children with severe pneumonia admitted to Beijing Changping Hospital of Integrated Chinese and Western Medicine from December 2020 to October 2023 were selected as the research subjects.They were divided into control group(38 cases)and observation group(38 cases)according to coin tossing.The control group was treated with Azithromycin combined with Methylprednisolone,while the observation group was treated with Human Immunoglobulin on the basis of control group.The treatment effect,the disappearance time of clinical symptoms,and serum C-reactive protein(CRP)level were compared between the two groups.Results The total effective rate of observation group was 97.37%,which was higher than that of control group(84.21%),the difference was statistically significant(P<0.05).The disappearance time of high fever,cough,shortness of breath,and lung rales in the observation group was shorter than that in the control group,and the difference was statistically significant(P<0.05).Before treatment,there was no significant difference in the CRP level between the two groups(P>0.05).After treatment,the CRP level in both groups decreased,and that in observation group was lower than that in control group,the difference was statistically significant(P<0.05).Conclusion The clinical effect of Human Immunoglobulin in the adjuvant treatment of severe pneumonia in children is good,which can promote the relief of symptoms and reduce inflammation,and is worth promoting.关键词
小儿重症肺炎/人免疫球蛋白/C反应蛋白Key words
Severe pneumonia in children/Human Immunoglobulin/C-reactive protein分类
临床医学
